Park YS - Search Results

1

Synthetic skin-permeable proteins enabling needleless immunization.

Huang Y, Park YS, Moon C, David AE, Chung HS, Yang VC. Huang Y, et al. Among authors: park ys. Angew Chem Int Ed Engl. 2010 Apr 1;49(15):2724-7. doi: 10.1002/anie.200906153. Angew Chem Int Ed Engl. 2010. PMID: 20232417 Free PMC article. No abstract available.

2

Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1alpha-oligonucleotide.

Park YS, Huang Y, Park YJ, David AE, White L, He H, Chung HS, Yang VC. Park YS, et al. Among authors: park yj. J Control Release. 2010 May 21;144(1):82-90. doi: 10.1016/j.jconrel.2010.01.026. Epub 2010 Jan 28. J Control Release. 2010. PMID: 20109509 Free PMC article.

3

ATTEMPTS system: a macromolecular prodrug strategy for cancer drug delivery.

Huang Y, Park YS, Wang J, Moon C, Kwon YM, Chung HS, Park YJ, Yang VC. Huang Y, et al. Among authors: park yj, park ys. Curr Pharm Des. 2010 Jul;16(21):2369-76. doi: 10.2174/138161210791920441. Curr Pharm Des. 2010. PMID: 20618157 Review.

4

A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo.

David AE, Cole AJ, Chertok B, Park YS, Yang VC. David AE, et al. Among authors: park ys. J Control Release. 2011 May 30;152(1):67-75. doi: 10.1016/j.jconrel.2011.01.033. Epub 2011 Feb 2. J Control Release. 2011. PMID: 21295085 Free PMC article.

5

Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination.

Lee TY, Park YS, Garcia GA, Sunahara RK, Woods JH, Yang VC. Lee TY, et al. Among authors: park ys. Mol Pharm. 2012 May 7;9(5):1361-73. doi: 10.1021/mp200623w. Epub 2012 Mar 28. Mol Pharm. 2012. PMID: 22404344 Free PMC article.

6

In vivo delivery of cell-permeable antisense hypoxia-inducible factor 1α oligonucleotide to adipose tissue reduces adiposity in obese mice.

Park YS, David AE, Huang Y, Park JB, He H, Byun Y, Yang VC. Park YS, et al. Among authors: park jb. J Control Release. 2012 Jul 10;161(1):1-9. doi: 10.1016/j.jconrel.2012.04.026. Epub 2012 Apr 23. J Control Release. 2012. PMID: 22546680 Free PMC article.

7

Controlled release of simvastatin from in situ forming hydrogel triggers bone formation in MC3T3-E1 cells.

Park YS, David AE, Park KM, Lin CY, Than KD, Lee K, Park JB, Jo I, Park KD, Yang VC. Park YS, et al. Among authors: park kd, park jb, park km. AAPS J. 2013 Apr;15(2):367-76. doi: 10.1208/s12248-012-9442-6. Epub 2012 Dec 19. AAPS J. 2013. PMID: 23250670 Free PMC article.

8

Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery.

Huang Y, Yu F, Park YS, Wang J, Shin MC, Chung HS, Yang VC. Huang Y, et al. Among authors: park ys. Biomaterials. 2010 Dec;31(34):9086-91. doi: 10.1016/j.biomaterials.2010.08.046. Epub 2010 Sep 9. Biomaterials. 2010. PMID: 20828812 Free PMC article.

9

Simvastatin maintains osteoblastic viability while promoting differentiation by partially regulating the expressions of estrogen receptors α.

Park JB, Zhang H, Lin CY, Chung CP, Byun Y, Park YS, Yang VC. Park JB, et al. Among authors: park ys. J Surg Res. 2012 May 15;174(2):278-83. doi: 10.1016/j.jss.2010.12.029. Epub 2011 Jan 15. J Surg Res. 2012. PMID: 21324392

10

Controlled release of clot-dissolving tissue-type plasminogen activator from a poly(L-glutamic acid) semi-interpenetrating polymer network hydrogel.

Park Y, Liang J, Yang Z, Yang VC. Park Y, et al. J Control Release. 2001 Jul 10;75(1-2):37-44. doi: 10.1016/s0168-3659(01)00360-1. J Control Release. 2001. PMID: 11451495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,254 results

Search Page

Filters